Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease.

Gibbs E, Silverman JM, Zhao B, Peng X, Wang J, Wellington CL, Mackenzie IR, Plotkin SS, Kaplan JM, Cashman NR.

Sci Rep. 2019 Jul 8;9(1):9870. doi: 10.1038/s41598-019-46306-5.

2.

Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training.

Karran M, Guerrero-Berroa E, Schmeidler J, Lee PG, Alexander N, Nabozny M, West RK, Beeri MS, Sano M, Silverman JM.

J Alzheimers Dis. 2019;69(2):401-411. doi: 10.3233/JAD-180952.

PMID:
31006684
3.

Short-term computerized cognitive training does not improve cognition compared to an active control in non-demented adults aged 80 years and above.

West RK, Rabin LA, Silverman JM, Moshier E, Sano M, Beeri MS.

Int Psychogeriatr. 2019 Apr 10:1-9. doi: 10.1017/S1041610219000267. [Epub ahead of print]

PMID:
30968798
4.

The Association of Depressive Symptoms With Brain Volume Is Stronger Among Diabetic Elderly Carriers of the Haptoglobin 1-1 Genotype Compared to Non-carriers.

Livny A, Schnaider Beeri M, Heymann A, Schmeidler J, Moshier E, Tzukran R, Tsarfaty G, Leroith D, Preiss R, Soleimani L, Guerrero-Berroa E, Silverman JM, Bendlin B, Levy A, Ravona-Springer R.

Front Endocrinol (Lausanne). 2019 Feb 12;10:68. doi: 10.3389/fendo.2019.00068. eCollection 2019.

5.

Distinct age-related associations for body mass index and cognition in cognitively healthy very old veterans.

Schmeidler J, Mastrogiacomo CN, Beeri MS, Rosendorff C, Silverman JM.

Int Psychogeriatr. 2019 Jun;31(6):895-899. doi: 10.1017/S1041610218001412. Epub 2019 Feb 5.

PMID:
30719960
6.

CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1.

Silverman JM, Christy D, Shyu CC, Moon KM, Fernando S, Gidden Z, Cowan CM, Ban Y, Stacey RG, Grad LI, McAlary L, Mackenzie IR, Foster LJ, Cashman NR.

J Biol Chem. 2019 Mar 8;294(10):3744-3759. doi: 10.1074/jbc.RA118.004825. Epub 2019 Jan 11.

PMID:
30635404
7.

Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes.

Soleimani L, Ravona-Springer R, Heymann A, Guerrero-Berroa E, Schmeidler J, Zukran R, Preiss R, Silverman JM, Sano M, Beeri MS.

Int Psychogeriatr. 2018 Dec 11:1-5. doi: 10.1017/S104161021800114X. [Epub ahead of print]

PMID:
30526693
8.

Depressive Symptoms Are Associated with Cognitive Function in the Elderly with Type 2 Diabetes.

Guerrero-Berroa E, Ravona-Springer R, Schmeidler J, Heymann A, Soleimani L, Sano M, Leroith D, Preiss R, Zukran R, Silverman JM, Beeri MS.

J Alzheimers Dis. 2018;65(2):683-692. doi: 10.3233/JAD-170778.

9.

Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics.

West RK, Ravona-Springer R, Livny A, Heymann A, Shahar D, Leroith D, Preiss R, Zukran R, Silverman JM, Schnaider-Beeri M.

J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):683-688. doi: 10.1093/gerona/gly090.

10.

A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.

Silverman JM, Gibbs E, Peng X, Martens KM, Balducci C, Wang J, Yousefi M, Cowan CM, Lamour G, Louadi S, Ban Y, Robert J, Stukas S, Forloni G, Hsiung GR, Plotkin SS, Wellington CL, Cashman NR.

ACS Chem Neurosci. 2018 Jul 18;9(7):1591-1606. doi: 10.1021/acschemneuro.7b00469. Epub 2018 Apr 16.

PMID:
29614860
11.

Outcome age-based prediction of successful cognitive aging by total cholesterol.

Silverman JM, Schmeidler J.

Alzheimers Dement. 2018 Jul;14(7):952-960. doi: 10.1016/j.jalz.2018.01.009. Epub 2018 Mar 5.

12.

The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old.

Silverman JM, Schmeidler J.

Med Hypotheses. 2018 Jan;110:9-14. doi: 10.1016/j.mehy.2017.10.022. Epub 2017 Oct 31.

13.

Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes.

Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Guerrero-Berroa E, Soleimani L, Sano M, Leroith D, Preiss R, Tzukran R, Silverman JM, Beeri MS.

Diabetes Care. 2017 Sep;40(9):1187-1193. doi: 10.2337/dc16-2754. Epub 2017 Jun 20.

14.

Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension.

Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2018 Aug;198:6-15. doi: 10.1016/j.schres.2017.05.013. Epub 2017 May 24.

15.

Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia.

Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, Silverman JM, Sprock J, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Light GA.

JAMA Psychiatry. 2017 Jan 1;74(1):37-46. doi: 10.1001/jamapsychiatry.2016.2980.

16.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA Jr, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T; Psychosis Endophenotypes International Consortium, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J; CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium.

Nat Genet. 2017 Jan;49(1):27-35. doi: 10.1038/ng.3725. Epub 2016 Nov 21. Erratum in: Nat Genet. 2017 Mar 30;49(4):651. Nat Genet. 2017 Sep 27;49(10 ):1558.

17.

Bacterial N-Glycosylation Efficiency Is Dependent on the Structural Context of Target Sequons.

Silverman JM, Imperiali B.

J Biol Chem. 2016 Oct 14;291(42):22001-22010. Epub 2016 Aug 29.

18.

Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women.

West RK, Ravona-Springer R, Heymann A, Schmeidler J, Leroith D, Koifman K, D'Arcy RC, Song X, Guerrero-Berroa E, Preiss R, Hoffman H, Sano M, Silverman JM, Schnaider-Beeri M.

Alzheimers Dement. 2016 Aug;12(8):925-9. doi: 10.1016/j.jalz.2016.03.017. Epub 2016 May 2.

19.

Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.

Greenbaum L, Ravona-Springer R, Lubitz I, Schmeidler J, Cooper I, Sano M, Silverman JM, Heymann A, Beeri MS.

Eur Neuropsychopharmacol. 2016 Apr;26(4):787-95. doi: 10.1016/j.euroneuro.2015.11.004. Epub 2015 Nov 14.

20.

Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways.

Silverman JM, Fernando SM, Grad LI, Hill AF, Turner BJ, Yerbury JJ, Cashman NR.

Cell Mol Neurobiol. 2016 Apr;36(3):377-81. doi: 10.1007/s10571-015-0294-3. Epub 2016 Feb 23. Review.

PMID:
26908139
21.

Neuropsychological Test Performance in Cognitively Normal Spanish-speaking Nonagenarians with Little Education.

Guerrero-Berroa E, Schmeidler J, Raventos H, Valerio D, Beeri MS, Carrión-Baralt JR, Mora-Villalobos L, Bolaños P, Sano M, Silverman JM.

J Cross Cult Gerontol. 2016 Jun;31(2):129-41. doi: 10.1007/s10823-016-9285-1.

22.

Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.

Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2016 Jan;170(1):30-40. doi: 10.1016/j.schres.2015.11.008. Epub 2015 Nov 18. Review.

23.

Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History.

Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL.

Am J Psychiatry. 2016 Apr 1;173(4):385-91. doi: 10.1176/appi.ajp.2015.15050605. Epub 2015 Oct 6.

24.

Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Guerrero-Berroa E, Ravona-Springer R, Heymann A, Schmeidler J, Hoffman H, Preiss R, Koifmann K, Greenbaum L, Levy A, Silverman JM, Leroith D, Sano M, Schnaider-Beeri M.

Int J Geriatr Psychiatry. 2016 May;31(5):494-501. doi: 10.1002/gps.4354. Epub 2015 Sep 21.

25.

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis.

Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, Zhao Q, Kendler KS, Sullivan PF, Price AL, O'Donovan M, Okada Y, Mowry BJ, Raychaudhuri S, Wray NR; Schizophrenia Working Group of the Psychiatric Genomics Consortium and Rheumatoid Arthritis Consortium International; Schizophrenia Working Group of the Psychiatric Genomics Consortium Authors, Byerley W, Cahn W, Cantor RM, Cichon S, Cormican P, Curtis D, Djurovic S, Escott-Price V, Gejman PV, Georgieva L, Giegling I, Hansen TF, Ingason A, Kim Y, Konte B, Lee PH, McIntosh A, McQuillin A, Morris DW, Nöthen MM, O'Dushlaine C, Olincy A, Olsen L, Pato CN, Pato MT, Pickard BS, Posthuma D, Rasmussen HB, Rietschel M, Rujescu D, Schulze TG, Silverman JM, Thirumalai S, Werge T; Schizophrenia Working Group of the Psychiatric Genomics Consortium Collaborators, Agartz I, Amin F, Azevedo MH, Bass N, Black DW, Blackwood DH, Bruggeman R, Buccola NG, Choudhury K, Cloninger RC, Corvin A, Craddock N, Daly MJ, Datta S, Donohoe GJ, Duan J, Dudbridge F, Fanous A, Freedman R, Freimer NB, Friedl M, Gill M, Gurling H, De Haan L, Hamshere ML, Hartmann AM, Holmans PA, Kahn RS, Keller MC, Kenny E, Kirov GK, Krabbendam L, Krasucki R, Lawrence J, Lencz T, Levinson DF, Lieberman JA, Lin DY, Linszen DH, Magnusson PK, Maier W, Malhotra AK, Mattheisen M, Mattingsdal M, McCarroll SA, Medeiros H, Melle I, Milanova V, Myin-Germeys I, Neale BM, Ophoff RA, Owen MJ, Pimm J, Purcell SM, Puri V, Quested DJ, Rossin L, Ruderfer D, Sanders AR, Shi J, Sklar P, St Clair D, Stroup TS, Van Os J, Visscher PM, Wiersma D, Zammit S; Rheumatoid Arthritis Consortium International Authors, Bridges SL Jr, Choi HK, Coenen MJ, de Vries N, Dieud P, Greenberg JD, Huizinga TW, Padyukov L, Siminovitch KA, Tak PP, Worthington J; Rheumatoid Arthritis Consortium International Collaborators, De Jager PL, Denny JC, Gregersen PK, Klareskog L, Mariette X, Plenge RM, van Laar M, van Riel P.

Int J Epidemiol. 2015 Oct;44(5):1706-21.

26.

Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).

Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2015 Apr;163(1-3):38-46. doi: 10.1016/j.schres.2015.01.017. Epub 2015 Mar 4.

27.

Glycemic control, inflammation, and cognitive function in older patients with type 2 diabetes.

Akrivos J, Ravona-Springer R, Schmeidler J, LeRoith D, Heymann A, Preiss R, Hoffman H, Koifman K, Silverman JM, Schnaider Beeri M.

Int J Geriatr Psychiatry. 2015 Oct;30(10):1093-100. doi: 10.1002/gps.4267. Epub 2015 Feb 20.

28.

Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1).

Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF.

Schizophr Res. 2015 Apr;163(1-3):73-9. doi: 10.1016/j.schres.2015.01.027. Epub 2015 Feb 11.

29.

Quantitative proteomic analysis reveals a simple strategy of global resource allocation in bacteria.

Hui S, Silverman JM, Chen SS, Erickson DW, Basan M, Wang J, Hwa T, Williamson JR.

Mol Syst Biol. 2015 Feb 12;11(1):784. doi: 10.15252/msb.20145697.

30.

Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies.

Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Sugar CA, Tsuang MT, Turetsky BI, Tsuang DW.

Schizophr Res. 2015 Apr;163(1-3):47-52. doi: 10.1016/j.schres.2014.12.016. Epub 2014 Dec 29.

31.

Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding.

Grad LI, Pokrishevsky E, Silverman JM, Cashman NR.

Prion. 2014;8(5):331-5. doi: 10.4161/19336896.2014.983398.

32.

Brief Report: Phenotypic Differences and their Relationship to Paternal Age and Gender in Autism Spectrum Disorder.

Vierck E, Silverman JM.

J Autism Dev Disord. 2015 Jun;45(6):1915-24. doi: 10.1007/s10803-014-2346-9.

PMID:
25526953
33.

California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS).

Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Seidman LJ.

Schizophr Res. 2015 Apr;163(1-3):32-7. doi: 10.1016/j.schres.2014.10.029. Epub 2014 Dec 12.

34.

Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Hazlett EA, Rothstein EG, Ferreira R, Silverman JM, Siever LJ, Olincy A.

Schizophr Res. 2015 Feb;161(2-3):283-90. doi: 10.1016/j.schres.2014.11.020. Epub 2014 Dec 5.

35.

Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI.

Schizophr Res. 2015 Apr;163(1-3):63-72. doi: 10.1016/j.schres.2014.09.042. Epub 2014 Oct 23.

36.

Self-injury in autism spectrum disorder: an effect of serotonin transporter gene promoter variants.

Kolevzon A, Lim T, Schmeidler J, Martello T, Cook EH Jr, Silverman JM.

Psychiatry Res. 2014 Dec 30;220(3):987-90.

PMID:
25446464
37.

Neurocognitive performance in family-based and case-control studies of schizophrenia.

Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Gur RE.

Schizophr Res. 2015 Apr;163(1-3):17-23.

38.

Shorter adult height is associated with poorer cognitive performance in elderly men with type II diabetes.

West RK, Ravona-Springer R, Heymann A, Schmeidler J, Leroith D, Koifman K, Guerrero-Berroa E, Preiss R, Hoffman H, Silverman JM, Beeri MS.

J Alzheimers Dis. 2015;44(3):927-35. doi: 10.3233/JAD-142049.

39.

Arterial wall function is associated with cognitive performance primarily in elderly with type 2 diabetes.

Ravona-Springer R, Haratz S, Tanne D, Schmeidler J, Efrati S, Rosendorff C, Beeri MS, Silverman JM.

J Alzheimers Dis. 2015;44(2):687-93. doi: 10.3233/JAD-141197.

40.

The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.

Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Light G.

Schizophr Res. 2015 Apr;163(1-3):53-62. doi: 10.1016/j.schres.2014.09.024. Epub 2014 Oct 11.

41.

Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications.

Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2015 Apr;163(1-3):24-31. doi: 10.1016/j.schres.2014.08.014. Epub 2014 Sep 22.

42.

The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Beeri MS, Ravona-Springer R, Moshier E, Schmeidler J, Godbold J, Karpati T, Leroith D, Koifman K, Kravitz E, Price R, Hoffman H, Silverman JM, Heymann A.

Alzheimers Dement. 2014 Nov;10(6):769-78. doi: 10.1016/j.jalz.2014.06.002. Epub 2014 Aug 20.

43.

The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.

Greenbaum L, Springer RR, Lutz MW, Heymann A, Lubitz I, Cooper I, Kravitz E, Sano M, Roses AD, Silverman JM, Saunders AM, Beeri MS.

Eur Neuropsychopharmacol. 2014 Sep;24(9):1492-9. doi: 10.1016/j.euroneuro.2014.06.002. Epub 2014 Jun 13.

44.

Dietary advanced glycation end products are associated with decline in memory in young elderly.

West RK, Moshier E, Lubitz I, Schmeidler J, Godbold J, Cai W, Uribarri J, Vlassara H, Silverman JM, Beeri MS.

Mech Ageing Dev. 2014 Sep;140:10-2. doi: 10.1016/j.mad.2014.07.001. Epub 2014 Jul 15.

45.

How predictive of dementia are inflammatory biomarkers in late midlife?

Di Napoli M, Silverman JM.

Neurology. 2014 Aug 5;83(6):478-9. doi: 10.1212/WNL.0000000000000662. Epub 2014 Jul 2. No abstract available.

PMID:
24991026
46.

Decreased motor function is associated with poorer cognitive function in elderly with type 2 diabetes.

Guerrero-Berroa E, Ravona-Springer R, Heymann A, Schmeidler J, Silverman JM, Sano M, Koifmann K, Preiss R, Hoffman H, Schnaider Beeri M.

Dement Geriatr Cogn Dis Extra. 2014 Apr 25;4(1):103-12. doi: 10.1159/000360280. eCollection 2014 Jan.

47.

Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings.

Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Stone WS, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Silverman JM.

Psychiatry Res. 2014 Sep 30;219(1):67-71. doi: 10.1016/j.psychres.2014.05.035. Epub 2014 May 28.

48.

Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study.

Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Bull. 2014 Nov;40(6):1404-11. doi: 10.1093/schbul/sbu064. Epub 2014 Jun 5.

49.

Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes.

Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, Sano M, Leroith D, Johnson S, Preiss R, Koifman K, Hoffman H, Silverman JM, Beeri MS.

PLoS One. 2014 Jun 2;9(6):e97384. doi: 10.1371/journal.pone.0097384. eCollection 2014.

50.

The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes.

Ravona-Springer R, Heymann A, Schmeidler J, Sano M, Preiss R, Koifman K, Hoffman H, Silverman JM, Beeri MS.

Eur Neuropsychopharmacol. 2014 Aug;24(8):1303-8. doi: 10.1016/j.euroneuro.2014.05.001. Epub 2014 May 14.

Supplemental Content

Loading ...
Support Center